Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Debt Ratio (2017 - 2026)

Updated

Entera Bio's Debt Ratio came in at 0.01 for Q2 2026, down 45.3% from 0.03 a year earlier and down 66.2% from the prior quarter.

Analysis

Entera Bio (ENTX) Debt Ratio (2017 - 2026) Analysis & Trends

For FY2025, Entera Bio's Debt Ratio was 0.02.

  • Business Quant data shows ENTX's Debt Ratio at 0.04 (Q1 2026), 0.02 (Q4 2025) and 0.03 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Entera Bio 563.51 Mn 269.58 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 0.00
Jun 30, 2026 0.01
Mar 31, 2026 0.04
Dec 31, 2025 0.02
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.02
Dec 31, 2017 0.29
API Access

Entera Bio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ENTX&period=max&api_key=YOUR_API_KEY